Rapid Ebola Diagnosis May Be Possible with New Technology

Booster Shots Offset Some Omicron Immune Evasion Tactics

Demonstration of a Potent, Universal Coronavirus Monoclonal Antibody Therapy for all COVID-19 Variants

Link Type
Funded-research
Publish or Event Date
Link URL
https://www.uab.edu/news/research/item/12986-demonstration-of-a-potent-universal-coronavirus-monoclonal-antibody-therapy-for-all-covid-19-variants
Research Institution
University of Alabama at Birmingham
Short Title
Demonstration of a Potent, Universal Coronavirus Monoclonal Antibody Therapy for all COVID-19 Variants
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Study Explores Role RSV Plays in Later Asthma Development

University of Maryland School of Medicine Expert Co-led Novavax Trial that Led to FDA Emergency Use Authorization and CDC Recommendation

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.medschool.umaryland.edu/news/2022/University-of-Maryland-School-of-Medicine-Expert-Co-led-Novavax-Trial-that-Led-to-FDA-Emergency-Use-Authorization-and-CDC-Recommendation.html
Research Institution
University of Maryland School of Medicine
Short Title
University of Maryland School of Medicine Expert Co-led Novavax Trial that Led to FDA Emergency Use Authorization and CDC Recommendation
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

ACTG Announces Publication Of #ACTIV-2 Study in Cell Reports Medicine Demonstrating Rapid Clearance of Culturable SARS-COV-2 Following Monoclonal Antibody Treatment

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://actgnetwork.org/2022/07/27/actg-announces-publication-of-activ-2-study-in-cell-reports-medicine-demonstrating-rapid-clearance-of-culturable-sars-cov-2-following-monoclonal-antibody-treatment/
Research Institution
ACTG
Short Title
ACTG Announces Publication Of #ACTIV-2 Study in Cell Reports Medicine Demonstrating Rapid Clearance of Culturable
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

UCLA Awarded $11.5 Million to Improve Organ, Hand and Face Transplantation

NIH, GreenLight Biosciences to Collaborate on COVID-19 Vaccine Development for New Variants

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.greenlightbiosciences.com/nih-greenlight-biosciences-to-collaborate-on-covid-19-vaccine-development-for-new-variants/
Research Institution
GreenLight Biosciences
Short Title
NIH, GreenLight Biosciences to Collaborate on COVID-19 Vaccine Development for New Variants
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Variant Type and Patient Sex Affect Molnupiravir Efficacy, Study Finds

Tiny Fruit Fly Holds Major Genetic Transfer Discovery

Subscribe to